Scarica l'app Stockscreener
0.30
0.00%
0.00
Precedente Chiudi:
$0.30
Aprire:
$0.3
Volume 24 ore:
100
Relative Volume:
0.03
Capitalizzazione di mercato:
$N/A
Reddito:
-
Utile/perdita netta:
$-7.98M
Rapporto P/E:
-1.5448
EPS:
-0.1942
Flusso di cassa netto:
$-5.84M
1 W Prestazione:
+0.00%
1M Prestazione:
-28.57%
6M Prestazione:
-71.96%
1 anno Prestazione:
-55.39%
Intervallo 1D:
$0.30
$0.30
Intervallo di 1 settimana:
$0.011
$0.36
Portata 52W:
$0.0004
$1.12
Anebulo Pharmaceuticals Inc Stock (ANEB) Company Profile
Nome
Anebulo Pharmaceuticals Inc
Settore
Industria
Telefono
-
Indirizzo
-
Compare ANEB vs VRTX, REGN, ARGX, MRNA, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ANEB
Anebulo Pharmaceuticals Inc
|
0.30 | 0 | 0 | -7.98M | -5.84M | -0.1942 |
VRTX
Vertex Pharmaceuticals Inc
|
508.34 | 130.64B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
784.85 | 80.46B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
990.32 | 61.58B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
154.04 | 57.48B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
190.95 | 43.68B | 742.00K | -1.37B | -1.07B | -7.0731 |
Anebulo Pharmaceuticals Inc Borsa (ANEB) Ultime notizie
Anebulo Pharmaceuticals Inc Revenue Breakdown – OTC:ANEB - TradingView
Anebulo Pharmaceuticals, Inc. Revenue Breakdown – LS:A3CM1D - TradingView
Stabilis Solutions And 2 Other High-Quality Penny Stocks For Savvy Investors - simplywall.st
Anebulo Pharmaceuticals (ANEB) Proxy Filing Summary - Quartr
Enterprise value to EBITDA forward of Anebulo Pharmaceuticals Inc – OTC:ANEB - TradingView
Total assets of Anebulo Pharmaceuticals from 2021 to 2025 - Statista
Enterprise value to revenue forward of Anebulo Pharmaceuticals Inc – OTC:ANEB - TradingView
Enterprise value to revenue forward of Anebulo Pharmaceuticals, Inc. – LSX:A3CM1D - TradingView
Price to sales forward of Anebulo Pharmaceuticals Inc – OTC:ANEB - TradingView
Anebulo Pharmaceuticals, Inc. Financial Disclosures & Filings - TradingView
Anebulo Pharmaceuticals, Inc. Actuals & Estimates (OTC:ANEB) - TradingView
Anebulo Pharmaceuticals Inc (ANEB) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Anebulo Pharmaceuticals Inc (ANEB) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Anebulo Pharmaceuticals Inc (ANEB) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Anebulo Pharmaceuticals Inc (ANEB) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Anebulo Pharmaceuticals Inc (ANEB) Valuation: PE, PB & Fair Value Analysis - TradingKey
Anebulo Pharmaceuticals Inc (ANEB) Institutional Confidence - TradingKey
Anebulo Pharmaceuticals Inc (ANEB) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Anebulo Pharmaceuticals Inc - TradingKey
Anebulo Pharmaceuticals Inc (ANEB) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
TradingKey - TradingKey
Anebulo’s Selonabant Phase 1 Completion: What Investors Should Watch Next - TipRanks
ANEB Price Today: Anebulo Pharmaceuticals, Inc. Stock Price, Quote & Chart | MEXC - mexc.co
Risk Recap: Why is Anebulo Pharmaceuticals Inc stock going downJobs Report & Real-Time Buy Signal Alerts - baoquankhu1.vn
Layoff Watch: Is Anebulo Pharmaceuticals Inc gaining market shareTrade Risk Report & Free Risk Controlled Daily Trade Plans - baoquankhu1.vn
Is Anebulo Pharmaceuticals Inc gaining market share2026 Earnings & Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Anebulo Pharmaceuticals, Inc. (ANEB) Stock Price, News, Quote & History - Yahoo! Finance Canada
Pullback Watch: Whats the beta of Anebulo Pharmaceuticals Inc stockWeekly Risk Report & Real-Time Market Sentiment Alerts - baoquankhu1.vn
Anebulo Pharmaceuticals, Inc. (214.F) stock price, news, quote and history - Yahoo Finance UK
Anebulo Pharmaceuticals Inc (ANEB) Dividends - The Globe and Mail
QCLS Stock Price and Chart — NASDAQ:QCLS - tradingview.com
ANEB SEC FilingsAnebulo Pharmaceuticals Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Anebulo Pharmaceuticals | 15-12G: Notice of termination of registration of a class of securities under Section 12(g) (and amendment thereto)moomoo - Moomoo
Anebulo Pharmaceuticals, Inc.(OTCPK: ANEB) dropped from NASDAQ Composite Index - marketscreener.com
Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB) Short Interest Up 188.7% in February - Defense World
12 Health Care Stocks Moving In Thursday's Pre-Market Session - benzinga.com
Anebulo Pharmaceuticals | 25: Notification of the removal from listing and registration of matured, redeemed or retired securities (and amendment thereto)moomoo - Moomoo
Dated alert on Anebulo Pharmaceuticals' voluntary delisting from Nasdaq withdrawn - marketscreener.com
Anebulo Pharmaceuticals stock plunges after announcing Nasdaq delisting plans By Investing.com - Investing.com Nigeria
Anebulo Pharmaceuticals stock plunges after announcing Nasdaq delisting plans - Investing.com
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Anebulo completes oversubscribed share repurchase tender offer - Investing.com
Drug developer drops reverse split, plans cash buyback to go private - Stock Titan
HIND Stock Price and Chart — NASDAQ:HIND - TradingView
KTTA Stock Price and Chart — NASDAQ:KTTA - TradingView
Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2026 Financial Results and Recent Updates - Business Wire
We're Hopeful That Anebulo Pharmaceuticals (NASDAQ:ANEB) Will Use Its Cash Wisely - Yahoo Finance
Anebulo Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Recent Updates - BioSpace
Anebulo Pharmaceuticals Announces Update on Going Private Transaction and Strategic Alternatives - ChartMill
On Thursday, there are stocks with unusual volume. Let's take a look. - ChartMill
Anebulo Pharmaceuticals stock soars after approving plan to go private By Investing.com - Investing.com UK
Anebulo Pharmaceuticals Inc Azioni (ANEB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.88%
Capitalizzazione:
|
Volume (24 ore):